ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2017

Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia.

Gregory W Hosier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.